Resistance to MPTP-Neurotoxicity in α-Synuclein Knockout Mice Is Complemented by Human α-Synuclein and Associated with Increased β-Synuclein and Akt Activation
2011

Human α-Synuclein and MPTP Toxicity in Mice

Sample size: 5 publication 10 minutes Evidence: moderate

Author Information

Author(s): Thomas Bobby, Mandir Allen S., West Neva, Liu Ying, Andrabi Shaida A., Stirling Wanda, Dawson Valina L., Dawson Ted M., Lee Michael K.

Primary Institution: Johns Hopkins University School of Medicine

Hypothesis

Does human α-synuclein expression affect the vulnerability of dopaminergic neurons to MPTP toxicity?

Conclusion

Human α-synuclein can replace mouse α-synuclein in terms of vulnerability to MPTP toxicity, but does not restore the developmental loss of dopaminergic neurons in α-synuclein null mice.

Supporting Evidence

  • Increased expression of human α-synuclein does not increase vulnerability of dopaminergic neurons to MPTP.
  • Human α-synuclein can restore MPTP-sensitivity in α-synuclein null mice.
  • MPTP treatment resulted in significant reductions in TH-positive neurons in all mouse lines.

Takeaway

The study shows that human α-synuclein doesn't make mice more sensitive to a toxin that affects brain cells, but it can help protect some brain cells from damage.

Methodology

Transgenic mice were treated with MPTP and analyzed for neuronal counts and dopamine levels.

Limitations

The study primarily focuses on acute MPTP toxicity and may not reflect chronic effects.

Participant Demographics

Transgenic mice, specifically those expressing human α-synuclein variants.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0016706

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication